Latest News for: fda
Edit
Family Farmstead (Raw Mild Cheddar; Raw Sharp Cheddar/Family Farmstead Dairy) Recall reason: Potential to be contaminated with Listeria monocytogenes. (FDA - Food and Drug Administration)
Public Technologies 11 Nov 2026
When a company announces a recall, market withdrawal, or safety alert, the FDA posts the company's announcement as a public service. FDA does not endorse either the product or the company ... October 15, 2026 FDA Publish Date ... Follow FDA.
Edit
Laub’s Feeding & Cubing (Grade A Mini Hay Cubes/Laub’s Feeding & Cubing) Recall reason: Potential to be contaminated with Clostridium Botulinum (FDA - Food and Drug Administration)
Public Technologies 11 Nov 2026
When a company announces a recall, market withdrawal, or safety alert, the FDA posts the company's announcement as a public service. FDA does not endorse either the product or the company ... November 10, 2026 FDA Publish Date ... Follow FDA.
Edit
Reference 1 - Memorandum from A. Thompson-Wood,Environmental Review Team, Office of Pre-Market Additive Safety, Office of Food Chemical Safety, Dietary Supplements and Innovation, Human Foods Program, FDA to D. Hlavaty, Division of Additives and Ingredients, Office of Post-Market Assessment, Office of Food Chemical Safety, Dietary Supplements and Innovation, Human Foods Program, FDA, October 21, (The eRulemaking Program)
Public Technologies 10 Nov 2026
). The text version of this document is not available ... Disclaimer ... (noodl. 135966774) .
Edit
November 9, 2026 - FDA Approves First Factor Xla Inhibitor to Help Prevent Stroke in Certain Adults at High Risk (FDA - Food and Drug Administration)
Public Technologies 10 Nov 2026
Joffe, M.D., MMSc, Director of the Office of Cardiology, Hematology, Endocrinology, and Nephrology in the FDA's Center for Drug Evaluation and Research ... The FDA granted Sunharbo Fast Track and Priority Review designations.
Edit
FDA says use of popular GLP-1 drugs may lead to a rare but very serious, ...
Penn Live 10 Nov 2026
The Food and Drug Administration said the highly popular GLP-1 drugs will now carry a new warning on their labels after several reports of vision loss among users ....
Edit
Rutland Herald
10 Nov 2026
FDA adds rare vision-loss warning to popular GLP-1 drugs
The Food and Drug Administration is adding a new warning about possible rare cases of vision loss reported with popular drugs used for weight loss and diabetes, such as Ozempic. FDA regulators on Monday said the warning information will be ....
Edit
FDA warns of rare ‘eye stroke’ risk from GLP-1 drugs
The Hill 10 Nov 2026
The Food and Drug Administration (FDA) on Monday required pharmaceutical ...
Edit
The Lufkin News
10 Nov 2026
Do Ozempic, Zepbound cause vision loss? New FDA warning explained
A new warning label has been placed on GLP-1 drugs sold in the United States after a spate of lawsuits and studies said the medications may cause some patients to go blind ....
Edit
FDA must take action on abortion pills now that election is over
Life Site 10 Nov 2026
(2022) ... .
Edit
GLP-1s must now include warning for potential increased risk of vision loss, FDA announces
CBS News 10 Nov 2026
Edit
FDA warns of rare vision-loss side effect from GLP-1 drugs
CBS News 10 Nov 2026
The Food and Drug Administration is adding a new warning about possible rare cases of vision loss reported with GLP-1 drugs like Ozempic, Wegovy and other brands ... .
Edit
Ozempic, Wegovy, Mounjaro Face New FDA Warning Over Potential Risk Of Serious Vision Loss
NDTV 10 Nov 2026
NAION is a condition caused by reduced blood flow to the optic nerve, which carries visual information from the eye to the brain. It can result in sudden, painless loss of vision in one eye and, in... .
Edit
Danger of sudden vision loss: the new FDA warning about GLP-1 weight loss injections
Ynet 10 Nov 2026- 1
- 2
- Next page »